Chronic Sildenafil for Severe Diaphragmatic Hernia
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Terminated
Change in clinical practice allowing chronic therapy at 6 weeks of age, incompatible with possibility of placebo beyond 6 weeks of age on study protocol
Listed as NCT00133679, this PHASE4 trial focuses on Hernia, Diaphragmatic and Hypertension, Pulmonary and remains terminated or withdrawn. Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, it has been updated 14 times since 2006, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
14 versions recorded-
Jan 2026 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
▶ Show 9 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
-
Feb 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Jan 2021 — Feb 2021 [monthly]
Terminated PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE4
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE4
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE4
-
Feb 2017 — Aug 2017 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Feb 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ann & Robert H Lurie Children's Hospital of Chicago
- Children's Hospital Los Angeles
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .